Review of the market of medicinal products for the treatment of bronchial asthma and COPD based on the results of 2016

The volume of the market for the medicinal products treating BA and COPD reached 17.8 billion by value and 44 million by volume in 2016, with a slight increase in sales compared to the previous period. People mostly purchase such medicinal product in the retail pharmacy segment, accounting for more than 70% by volume and more than 50% by value. The preferential provision of anti-asthmatic drugs and drugs for COPD treatment accounts for about 40% in rubles and about 15% in packages, in the overall drug supply structure.

¹ ATC code R03, drugs for the treatment of asthma or COPD (EphMRA).



The reproduction of materials is allowed only if the limitations established by the Rightholder are observed, with mention of the author of the materials used and the reference to ALPHARM LLC as a source, with a mandatory hyperlink to website.